These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35486183)

  • 1. Expression and clinical prognostic value of CYB561 in breast cancer.
    Zhou X; Shen G; Ren D; Guo X; Han J; Guo Q; Zhao F; Wang M; Dong Q; Li Z; Zhao J
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):1879-1892. PubMed ID: 35486183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYB561 is a potential therapeutic target for breast cancer and is associated with immune cell infiltration.
    Zhuo J; Zhao Y; Hao R; Li H; Zheng Z; Dai L; Sheng A; Yao H; Tang Y; Wang R; Yang X; Liu W
    Eur J Med Res; 2024 Aug; 29(1):414. PubMed ID: 39135107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer.
    Yang X; Zhao Y; Shao Q; Jiang G
    Int J Gen Med; 2021; 14():10447-10464. PubMed ID: 35002301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.
    Gao T; Jiang B; Zhou Y; He R; Xie L; Li Y
    Front Immunol; 2024; 15():1369892. PubMed ID: 38707897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome b561 regulates iron metabolism by activating the Akt/mTOR pathway to promote Breast Cancer Cells proliferation.
    Zhou X; Guo X; Han J; Wang M; Liu Z; Ren D; Zhao J; Li Z
    Exp Cell Res; 2023 Oct; 431(1):113760. PubMed ID: 37634562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer.
    Fan X; Qi A; Zhang M; Jia Y; Li S; Han D; Liu Y
    Diagn Pathol; 2024 Aug; 19(1):113. PubMed ID: 39175074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
    Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
    Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of PLEKHA4 and its correlation with tumor-infiltrating immune cells in breast cancer: a comprehensive study based on bioinformatics and clinical analysis validation.
    Li L; Feng Z; Zhao Y; Lai B; Zhang Q; Xiong Z; Zhang W
    Transl Cancer Res; 2024 Sep; 13(9):4957-4972. PubMed ID: 39430828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and immunological value of
    Wang J; Liu Y; Zhang S
    Aging (Albany NY); 2021 Jul; 13(13):16904-16921. PubMed ID: 34228637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced Expression of KRT17 Predicts Poor Prognosis in HER2
    Tang S; Liu W; Yong L; Liu D; Lin X; Huang Y; Wang H; Cai F
    Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation.
    Zhao T; Gao P; Li Y; Tian H; Ma D; Sun N; Chen C; Zhang Y; Qi X
    Front Immunol; 2023; 14():1074242. PubMed ID: 37122728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 17. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
    Qiu Y; Lu G; Wu Y
    J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Features, Tumor Mutational Burden, and Tumour-Infiltrating Lymphocyte Interplay in
    Uchida S; Kojima T; Sugino T
    Pathol Oncol Res; 2021; 27():633243. PubMed ID: 34257600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
    Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
    World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.